Pharmacogenomics-based systematic review of coronary artery disease based on personalized medicine procedure.

Background: Coronary artery disease (CAD) is the most common reason for mortality and disability-adjusted life years (DALYs) lost globally. This study aimed to suggest a new gene list for the treatment of CAD by a systematic review of bioinformatics analyses of pharmacogenomics impacts of potential genes and variants.

Methods: PubMed search was filtered by the title including Coronary Artery Disease during 2020-2023.

Progress in cardiac tissue engineering and regeneration: Implications of gelatin-based hybrid scaffolds.

Cardiovascular diseases, particularly myocardial infarction (MI), remain a leading cause of morbidity and mortality worldwide. Current treatments for MI, more palliative than curative, have limitations in reversing the disease completely. Tissue engineering (TE) has emerged as a promising strategy to address this challenge and may lead to improved therapeutic approaches for MI.